PATHRYVA
Live / Registered — Registered (as of 23 Jan 2024)
What this means for you
Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97197222
- Registration number
- 7282981
- Mark type
- Stylized text
- Filed
- 30 Dec 2021
- Published for opposition
- 07 Nov 2023
- Registered
- 23 Jan 2024
- Attorney of record
- Shannon Marie McKeon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorders, pharmaceutical preparations for the treatment of endocrine disorders, pharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting hypoparathyroidism, endocrine disorders and bone disorders
Owner
- Ascendis Pharma Endocrinology Division A/S, Hellerup, DK
- Ascendis Pharma Endocrinology Division A/S, Hellerup, DK
- Ascendis Pharma Endocrinology Division A/S, Hellerup, DK
Prosecution history
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 07 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Nov 2023 — PUBLISHED FOR OPPOSITION
- 18 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jun 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Jun 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 22 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Mar 2023 — NON-FINAL ACTION E-MAILED
- 22 Mar 2023 — NON-FINAL ACTION WRITTEN
- 08 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED